AstraZeneca
AZN
#63
Rank
C$367.19 B
Marketcap
C$236.76
Share price
-0.23%
Change (1 day)
22.34%
Change (1 year)

Market capitalization of AstraZeneca (AZN)

Market cap: C$367.19 Billion

As of July 2026 AstraZeneca has a market cap of C$367.19 Billion. This makes AstraZeneca the world's 63th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of AstraZeneca from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026C$367.19 B-6.86%
2025C$394.23 B34.93%
2024C$292.17 B5.31%
2023C$277.44 B-2.82%
2022C$285.48 B23.44%
2021C$231.27 B38.47%
2020C$167.01 B-2.29%
2019C$170.92 B32.89%
2018C$128.62 B17.42%
2017C$109.54 B18.19%
2016C$92.67 B-22.73%
2015C$119.93 B15.39%
2014C$103.93 B31.76%
2013C$78.88 B35.32%
2012C$58.29 B-5.33%
2011C$61.57 B-5.36%
2010C$65.05 B-9.22%
2009C$71.66 B-0.76%
2008C$72.21 B16.02%
2007C$62.23 B-34.84%
2006C$95.51 B5.11%
2005C$90.87 B26.47%
2004C$71.85 B-32.37%
2003C$106.25 B11.55%
2002C$95.25 B-26.48%
2001C$129.56 B-4.91%
2000C$136.25 B27.41%
1999C$106.94 B63.18%
1998C$65.53 B34.25%
1997C$48.81 B34.38%
1996C$36.32 B

End of Day market cap according to different sources

On Jul 17th, 2026 the market cap of AstraZeneca was reported to be:

C$366.98 Billion
by Nasdaq info icon info icon
C$367.19 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
C$853.86 B 132.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$411.27 B 12.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$200.13 B-45.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$245.82 B-33.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$1.473 T 301.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$149.86 B-59.19%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
C$42.63 B-88.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$441.43 B 20.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$173.87 B-52.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$145.31 B-60.42%๐Ÿ‡ฌ๐Ÿ‡ง UK